A review of UK publicly funded non-inferiority trials: is the design more inferior than it should be?

Authors: Nikki Totton, Steven Julious, Stephen Walters, Elizabeth Coates

Source: Trials, Vol 25, Iss 1, Pp 1-12 (2024)

Subject Terms: Non-inferiority trials, Non-inferiority margin, Margin justification, Analysis population, Review, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1745-6215

Access URL: https://doaj.org/article/773e56a761764514b7c8707e74d5ff1c

Optimization the design of fixed and group sequential three-arm non-inferiority trials with dichotomous endpoints of risk difference and odds ratio

Authors: Wenwen Wang, Yaru Huang, Jielai Xia, Ling Wang, Chen Li

Source: Contemporary Clinical Trials Communications, Vol 42, Iss , Pp 101383- (2024)

Subject Terms: Risk difference, Three-arm non-inferiority trials, Group sequential clinical trial, Odds ratio, Dichotomous, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2451865424001303; https://doaj.org/toc/2451-8654

Access URL: https://doaj.org/article/f33206512c224be6a1f33ada0cc21c13

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Authors: Zhenzhen Liang, Xu Chen, Bo Xing, Xiaosong Hu, Miaomiao Liu, Xinpei Zhang, Yugang Shen, Yan Wang, Yingping Chen, Huakun Lv, Yu Mao

Source: Frontiers in Immunology, Vol 15 (2024)

Subject Terms: lyophilized human rabies vaccine (Vero cells), Essen and Zagreb regimens, immunogenicity, safety, non-inferiority (trials), Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1444686/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/429f373220c944c18694d93c90a36618

How do we know a treatment is good enough? A survey of non-inferiority trials

Authors: Naomi Attard, Nikki Totton, Katie Gillies, Beatriz Goulao

Source: Trials, Vol 23, Iss 1, Pp 1-10 (2022)

Subject Terms: Non-inferiority trials, Elicitation methods, Opinion seeking, Margin justification, Evidence-based, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1745-6215

Access URL: https://doaj.org/article/be3a40825d4f438e8b8ae7bad4d9cb78

Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review

Authors: Komorowski, Adam S. ^{1, 2, ∗}, Bai, Anthony D. ^{2, 4}, Cvetkovic, Anna ³, Mourad, Omar ³, Lo, Carson K.L. ³, Li, Xena X. ^{1, 3}, Mokashi, Vaibhav ³, Findlater, Aidan ³, Duncan, D. Brody ¹, Fuller, Charlotte ¹, Yamamura, Deborah ^{1, 3}, Mertz, Dominik ³

Source: In Clinical Microbiology and Infection May 2022 28(5):640-648

Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials

Authors: Anthony D. Bai, Adam S. Komorowski, Carson K. L. Lo, Pranav Tandon, Xena X. Li, Vaibhav Mokashi, Anna Cvetkovic, Aidan Findlater, Laurel Liang, George Tomlinson, Mark Loeb, Dominik Mertz, the McMaster Infectious Diseases Fellow Research Group

Source: Trials, Vol 22, Iss 1, Pp 1-10 (2021)

Subject Terms: Non-inferiority trials, Confidence interval, Statistics, Risk differences, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1745-6215

Access URL: https://doaj.org/article/c338145950834745b158fc6611a61acc

Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review

Authors: Anthony D. Bai, Adam S. Komorowski, Carson K. L. Lo, Pranav Tandon, Xena X. Li, Vaibhav Mokashi, Anna Cvetkovic, Aidan Findlater, Laurel Liang, George Tomlinson, Mark Loeb, Dominik Mertz, for the McMaster Infectious Diseases Fellow Research Group

Source: BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-10 (2021)

Subject Terms: Non-inferiority trials, Intention-to-treat, Per protocol, Systematic review, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2288

Access URL: https://doaj.org/article/b1fb4bcf333d4b40b49065693f3aef18

A Review of: “ Design and Analysis of Non-Inferiority Trials , by M. D. Rothmann, B. L. Wiens, and I. S. F. Chan”.

Authors: Witte, Steffen¹ (AUTHOR)

Source: Journal of Biopharmaceutical Statistics. Sep/Oct2012, Vol. 22 Issue 5, p1084-1087. 4p.

Subject Terms: Clinical drug trials, Nonfiction

Reviews & Products: Design & Analysis of Non-Inferiority Trials (Book)

People: Rothmann, M. D., Wiens, B. L., Chan, I. S. F.

Design and Analysis of Non-inferiority Trials by Mark D. Rothmann, Brian L. Wiens and Ivan S. F. Chan.

Authors: Brittain, Erica¹ ebrittain@niaid.nih.gov

Source: Australian & New Zealand Journal of Statistics. Mar2012, Vol. 54 Issue 1, p127-129. 3p.

Subject Terms: *CLINICAL trials, *NONFICTION

Reviews & Products: DESIGN & Analysis of Non-Inferiority Trials (Book)

People: ROTHMANN, Mark D., WIENS, Brian L., CHAN, Ivan S. F.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.